Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring and impulse control, not drug-specific traits.

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Alcohol addiction, also known as alcohol use disorder, is a serious problem that affects millions of people around the world.

GLP-1s seem to have more malleable uses than what they were created for. Popular drugs like Ozempic, Wegovy, and Mounjaro are meant for diabetic patients, but in recent years, people have leaned on ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, according to new research. The study found participants on these medications felt ...

GLP-1 drugs for weight loss and diabetes may slow the rate at which alcohol enters the bloodstream, a small new study finds. Note: While research on alcohol is evolving, the World Health Organization ...

For years, the Alcohol vs. Cannabis debate seemed settled for many people. Alcohol was viewed as the obvious villain, linked to violence, addiction, liver disease, and fatal crashes. Cannabis, by ...